Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05506878 · ClinicalTrials.gov registry record · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
A NA study of Opioid Use and Liver Transplant, sponsored by Jacques E. Chelly.
- Recruiting
- Registry status
- NA
- Development phase
- 286
- Enrollment target
- 4
- Study locations
NCT05506878 is a NA study of Opioid Use and Liver Transplant that is actively recruiting participants, run by Jacques E. Chelly. The registered enrollment target is 286 participants, below the 148,257-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT05506878, a NA study of Opioid Use and Liver Transplant, is actively recruiting participants, sponsored by Jacques E. Chelly.
- RECRUITING
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
- 4
- Study locations
Study Summary
The NSS-2 BRIDGE® device (NSS stands for Neuro-Stimulation System) is a disposable device that stimulates the branches of cranial nerves and of the superficial cervical plexus innervating the ear. Because the stimulation of the nerves of the ear by the NSS-2 BRIDGE® device (NBD®) has been shown to modulate pain pathways in rodents, decrease abdominal pain in adolescents with inflammatory bile syndrome and due to the results of our preliminary pilot study, the investigators hypothesized that this technique may also be effective in reducing the requirement for postoperative opioids and provide a non-pharmacological alternative to perioperative opioid use. To establish the role that the stimulation of the nerves of the ear may have in reducing postoperative opioid requirement, the investigators are proposing to conduct a randomized, placebo controlled study in patients undergoing open abdominal or pelvic surgery requiring at least 5 days of hospitalization. Subjects who have signed an informed consent will be randomized in 2 groups (active NBD® group or inactive NBD® group). Furthermore, since preoperative and postoperative mood disorders have been shown to increase postoperative pain levels and opioid requirement by up to 50%, the investigators further hypothesize that the stimulation of the ear nerves by the NSS-2 BRIDGE® effects may be in part mediated by a reduction of the level of anxiety, depression and catastrophizing as assessed using validated questionnaires.
Conditions Studied
Interventions
- DEVICE NSS-2 BRIDGE
- DEVICE Sham NSS-2 BRIDGE
Study Locations (4)
Pennsylvania
- University of Pittsburgh Medical Center - Magee-Womens Hospital - Pittsburgh
- UPMC Montefiore Hospital - Pittsburgh
- University of Pittsburgh Medical Center - Shadyside Hospital - Pittsburgh
- University of Pittsburgh Medical Center - Passavant Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2022-10-24 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05506878
The ClinicalTrials.gov registry entry for NCT05506878 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 286 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,257-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Jacques E. Chelly, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which NSS-2 BRIDGE is the first listed.
NCT05506878 reports 4 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05506878 about?
NCT05506878 is a clinical study titled "Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement". The NSS-2 BRIDGE® device (NSS stands for Neuro-Stimulation System) is a disposable device that stimulates the branches of cranial nerves and of the superficial cervical plexus innervating the ear. Because the stimulation of the nerves of the ear by the NSS-2 BRIDGE® device (NBD®) has been shown to m...
What is the current status of trial NCT05506878?
This trial is currently recruiting. It is a NA study. The enrollment target is 286 participants. The study started on 2022-10-24. Estimated completion is 2026-09-30.
What conditions does trial NCT05506878 study?
This clinical trial studies the following conditions: Opioid Use, Liver Transplant, Cancer Pain, Auriculotherapy, Pain, Abdominal.
What interventions are being tested in trial NCT05506878?
The interventions under investigation include: NSS-2 BRIDGE (DEVICE), Sham NSS-2 BRIDGE (DEVICE).
Who is sponsoring clinical trial NCT05506878?
This trial is sponsored by Jacques E. Chelly, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05506878 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.